{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-083131","form_type":"8-K","ticker":"SRPT","cik":"0000873303","company_name":"Sarepta Therapeutics, Inc.","filed_at":"2025-06-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.532912+00:00","generated_at":"2026-05-19T19:14:47.692518+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Sarepta shareholders approve 4.3M share increase to 2018 equity plan, 0.3M to ESPP","bullets":["Vote approves adding 4,300,000 shares to 2018 Equity Incentive Plan (total now 17,487,596).","Vote approves adding 300,000 shares to 2016 ESPP (total now 1,700,000 shares).","Re-elected directors Barry, Behrens, Mayo, Nicaise with majority support.","Advisory vote on 2024 named executive officer compensation passed (72.1M for, 2.2M against).","Ratified KPMG as independent auditor for FY2025 (80.6M for, 3.9M against)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-083131","json":"https://secwatch.observer/filing/0000950170-25-083131.json","markdown":"https://secwatch.observer/filing/0000950170-25-083131.md","text":"https://secwatch.observer/filing/0000950170-25-083131.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/873303/000095017025083131/0000950170-25-083131-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/873303/000095017025083131/srpt-20250605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T19:14:47.692518+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}